2021 annual financial data
Seres Therapeutics 2021 Financial results
Direct answer
Revenue was 144.93M USD.
Operating income was -64.49M USD and net income was -65.58M USD.
Operating cash flow was 6.69M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 144.93M USD
- Operating income
- -64.49M USD
- Net income
- -65.58M USD
- Operating cash flow
- 6.69M USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Seres Therapeutics financial years